| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AVITA Medical, Inc. | Chief Operating Officer | Common Stock | 46,450 | $578,303 | $12.45 | 01 Jul 2022 | Direct |
| Zosano Pharma Corp | Director | Stock Option (Right to Buy) | 90,000 | 24 May 2021 | Direct | ||
| AVITA Medical, Inc. | Chief Operating Officer | Stock Options (Right to Buy) | 20,650 | 01 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RCEL | AVITA Medical, Inc. | 01 Jul 2022 | 2 | $0 | 4 | Chief Operating Officer | 06 Jul 2022, 18:55 |
| RCEL | AVITA Medical, Inc. | 06 Jul 2021 | 2 | $0 | 4 | Chief Operating Officer | 07 Sep 2021, 16:05 |
| /report/000156761921011165-mcgee-kathy-m-2021-05-24 | Zosano Pharma Corp | 24 May 2021 | 1 | $0 | 4 | Director | 25 May 2021, 18:29 |
| /report/000156761921011161-mcgee-kathy-m-2021-05-24 | Zosano Pharma Corp | 24 May 2021 | 0 | $0 | 3 | Director | 25 May 2021, 18:11 |